Infusense Corp

Infusense Corp is a small research company based in Memphis, Tennessee. With four employees, the company has generated $2.5 million in revenue. Infusense Corp's platform is poised to revolutionize the way lipophilic drugs are measured and quantified using cutting-edge electrochemistry. Their primary focus lies in developing a novel platform for the precise measurement and quantification of lipophilic drugs. This technology has the potential to significantly impact various fields, including pharmaceuticals and drug development. Infusense Corp distinguishes itself through its innovative approach to drug analysis. By leveraging electrochemistry, they aim to provide a more accurate and efficient method for characterizing lipophilic drugs, which are often difficult to analyze using traditional techniques. For further information about Infusense Corp and its groundbreaking platform, please visit their website at infusense.com.